Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | EVP & Pres Med.Essntl&BioPharm | June 24, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date June 24, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,172 |
Reported balance
After 2026-06-24 transaction · row 1
1 source rowRow 1 · 2026-06-24 · Sale · Disposed 1,100 · Balance 13,172 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Jun 25, 2026 14:16 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,100 | $145.66 | $160,226.00 |
DisclosureSEC source: 0001628280-26-045374 · wk-form4_1782396959.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,172 Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 21:21 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,100 | $151.48 | $166,628.00 |
DisclosureSEC source: 0001628280-26-042571 · wk-form4_1781212873.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,272 F1 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 3,054 | $0.00 Strike: $167.91 | $0.00 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · derivative · entry 5 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,054 shares Expires 2026-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four annual installments beginning one year from the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,010 | $206.54 | $208,605.40 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 4 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,095 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 600 | $209.00 | $125,400.00 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,105 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 2,454 | $209.00 | $512,886.00 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,705 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 3,054 | $167.91 | $512,797.14 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 01:12 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 629 | $196.03 | $123,302.87 |
DisclosureSEC source: 0001628280-25-057774 · wk-form4_1766020374.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,105 Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 1,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054351 · wk-form4_1764608979.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,734 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 3,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054351 · wk-form4_1764608979.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,503 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 7,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054351 · wk-form4_1764608979.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,455 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 21:29 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 6,360 | $0.00 Strike: $147.68 | $0.00 |
DisclosureSEC source: 0001062993-25-013065 · form4.xml · derivative · entry 5 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,360 shares Expires 2025-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four annual installments beginning one year after grant. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 21:29 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1 | $181.50 | $181.50 |
DisclosureSEC source: 0001062993-25-013065 · form4.xml · nonDerivative · entry 4 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,887 Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 21:29 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,184 | $180.29 | $213,463.36 |
DisclosureSEC source: 0001062993-25-013065 · form4.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,888 Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 21:29 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 5,175 | $180.29 | $933,000.75 |
DisclosureSEC source: 0001062993-25-013065 · form4.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,072 Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 21:29 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 6,360 | $147.68 | $939,244.80 |
DisclosureSEC source: 0001062993-25-013065 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2025 Filed Apr 10, 2025 17:56 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 479 | $197.28 | $94,497.12 |
DisclosureSEC source: 0001062993-25-007297 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,887 Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 17:08 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 178 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004225 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,366 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of restricted stock units previously reported on Table I. Read SEC document |
| January 17, 2025 Filed Jan 21, 2025 13:21 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 597 | $236.51 | $141,196.47 |
DisclosureSEC source: 0001062993-25-000913 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,544 Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 15:18 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 2,838 | $223.33 | $633,810.54 |
DisclosureSEC source: 0001062993-24-020955 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,141 Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 14:59 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 10,004 | $0.00 Strike: $224.25 | $0.00 |
DisclosureSEC source: 0001062993-24-019796 · form4.xml · derivative · entry 4 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,004 Underlying: Common Stock · 10,004 shares Expires 2034-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2025. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 14:59 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 1,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019796 · form4.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,979 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 14:59 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 2,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019796 · form4.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,209 F2 · shares: Represents shares received upon vesting of performance based equity award. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 14:59 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 2,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019796 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,934 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| April 30, 2024 Filed May 1, 2024 16:59 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,715 | $232.81 | $399,269.15 |
DisclosureSEC source: 0001062993-24-009136 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,381 Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:16 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 178 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005404 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,096 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of restricted stock units previously reported on Table I. Read SEC document |
| December 11, 2023 Filed Dec 12, 2023 21:31 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,239 | $232.46 | $288,017.94 |
DisclosureSEC source: 0001062993-23-022437 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,274 Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:21 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 10,364 | $0.00 Strike: $238.89 | $0.00 |
DisclosureSEC source: 0001062993-23-021553 · form4.xml · derivative · entry 4 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,364 Underlying: Common Stock · 10,364 shares Expires 2033-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:21 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 1,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-021553 · form4.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,513 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:21 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 3,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-021553 · form4.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,159 F2 · shares: Represents shares received upon vesting of performance based equity award. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:21 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-021553 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,028 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 18:41 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,300 | $277.13 | $360,269.00 |
DisclosureSEC source: 0001062993-23-016073 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,157 F1 · price: The reported sale price reflects the weighted average sale price for two transactions. The actual sales prices for the transactions were $276.27 and $280.00. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:07 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 193 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005948 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,457 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 9,466 | $0.00 Strike: $238.06 | $0.00 |
DisclosureSEC source: 0001062993-22-022921 · form4.xml · derivative · entry 4 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,466 Underlying: Common Stock · 9,466 shares Expires 2032-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 617 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022921 · form4.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022921 · form4.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,267 F2 · shares: Represents shares received upon vesting of performance based equity award. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022921 · form4.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & President Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,044 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.